Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Silvia Hofer

Showing results (31-40 of 67) with videos related to

Pageof 7
Sort By:
Neurology|February 17, 2010
Cancer risk among patients with multiple sclerosis and their parentsSilvia Hofer, Michael Linnebank, Michael Weller, et al.
Cancers|February 25, 2023
Electronic Patient Reported Outcome (ePRO) Measures in Patients with Soft Tissue Sarcoma (STS) Receiving Palliative TreatmentSilvia Hofer, Leopold Hentschel, Stephan Richter, et al.
Journal of Neuro-Oncology|April 22, 2009
Early metabolic responses in temozolomide treated low-grade glioma patientsMatthias Wyss, Silvia Hofer, Matthias Bruehlmeier, et al.
Journal of Neurochemistry|May 13, 2011
A specific miRNA signature in the peripheral blood of glioblastoma patientsPatrick Roth, Jörg Wischhusen, Caroline Happold, et al.
Journal of Craniovertebral Junction & Spine|July 1, 2021
Spondylectomy in the treatment of neoplastic spinal lesions - A retrospective outcome analysis of 582 patients using a patient-level meta-analysisAlexander Spiessberger, Nicholas Dietz, Varun Arvind, et al.
Frontiers in Oncology|December 29, 2022
Metastatic mesenchymal chondrosarcoma showing a sustained response to cabozantinib: A case reportVeronika Blum, Vanghelita Andrei, Baptiste Ameline, et al.
Acta Oncologica (Stockholm, Sweden)|May 28, 2014
Addition of lomustine for bevacizumab-refractory recurrent glioblastomaMichaela Tonder, Günter Eisele, Tobias Weiss, et al.
Acta Neuropathologica Communications|August 28, 2023
MGMT methylation pattern of long-term and short-term survivors of glioblastoma reveals CpGs of the enhancer region to be of high prognostic valueHenning Leske, Ulrike Camenisch Gross, Silvia Hofer, et al.
European Journal of Dermatology : EJD|January 17, 2018
Nivolumab for recurrent cutaneous squamous cell carcinoma: three casesVeronika Blum, Beat Müller, Silvia Hofer, et al.
World Neurosurgery|March 24, 2015
Efficacy of Surgery and Further Treatment of Progressive GlioblastomaChristoph Michael Woernle, Dominik Péus, Silvia Hofer, et al.
Pageof 7

Showing results (31-40 of 67) with videos related to

Sort By:
Pageof 7
Neurology|February 17, 2010
Cancer risk among patients with multiple sclerosis and their parentsSilvia Hofer, Michael Linnebank, Michael Weller, et al.
Cancers|February 25, 2023
Electronic Patient Reported Outcome (ePRO) Measures in Patients with Soft Tissue Sarcoma (STS) Receiving Palliative TreatmentSilvia Hofer, Leopold Hentschel, Stephan Richter, et al.
Journal of Neuro-Oncology|April 22, 2009
Early metabolic responses in temozolomide treated low-grade glioma patientsMatthias Wyss, Silvia Hofer, Matthias Bruehlmeier, et al.
Journal of Neurochemistry|May 13, 2011
A specific miRNA signature in the peripheral blood of glioblastoma patientsPatrick Roth, Jörg Wischhusen, Caroline Happold, et al.
Journal of Craniovertebral Junction & Spine|July 1, 2021
Spondylectomy in the treatment of neoplastic spinal lesions - A retrospective outcome analysis of 582 patients using a patient-level meta-analysisAlexander Spiessberger, Nicholas Dietz, Varun Arvind, et al.
Frontiers in Oncology|December 29, 2022
Metastatic mesenchymal chondrosarcoma showing a sustained response to cabozantinib: A case reportVeronika Blum, Vanghelita Andrei, Baptiste Ameline, et al.
Acta Oncologica (Stockholm, Sweden)|May 28, 2014
Addition of lomustine for bevacizumab-refractory recurrent glioblastomaMichaela Tonder, Günter Eisele, Tobias Weiss, et al.
Acta Neuropathologica Communications|August 28, 2023
MGMT methylation pattern of long-term and short-term survivors of glioblastoma reveals CpGs of the enhancer region to be of high prognostic valueHenning Leske, Ulrike Camenisch Gross, Silvia Hofer, et al.
European Journal of Dermatology : EJD|January 17, 2018
Nivolumab for recurrent cutaneous squamous cell carcinoma: three casesVeronika Blum, Beat Müller, Silvia Hofer, et al.
World Neurosurgery|March 24, 2015
Efficacy of Surgery and Further Treatment of Progressive GlioblastomaChristoph Michael Woernle, Dominik Péus, Silvia Hofer, et al.
Pageof 7